Advantages and Limitations of the Neonatal Immune System

Frontiers in Pediatrics

Volumn 8, Issue , 2020, Pages

  Tsafaras, George P ^a   Ntontsi, Polyxeni ^b   Xanthou, Georgina ^a  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

brain injury; infections; innate immunity; neonates; neurodevelopment; sepsis

Indexed keywords

ANTIGEN PRESENTING CELL; EPIGENETICS; GRANULOCYTE; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INFECTION; INNATE IMMUNITY; LYMPHOID CELL; METABOLOME; MICROBIOME; NATURAL KILLER CELL; NERVE CELL DIFFERENTIATION; NEWBORN; PHAGOCYTE; REVIEW; SEPSIS; TISSUE INJURY;

EID: 85079507542     PISSN: None     EISSN: 22962360     Source Type: Journal    
DOI: 10.3389/fped.2020.00005     Document Type: Review

References (107)

1. Swanson JR, Sinkin RA. Transition from fetus to newborn. Pediatr Clin North Am. (2015) 62:329–43. 10.1016/j.pcl.2014.11.00225836701
2. McAdams RM, Juul SE. The role of cytokines and inflammatory cells in perinatal brain injury. Neurol Res Int. (2012) 2012:561494. 10.1155/2012/56149422530124
3. Milgrom J, Gemmill AW, Bilszta JL, Hayes B, Barnett B, Brooks J, et al. Antenatal risk factors for postnatal depression: a large prospective study. J Affect Disord. (2008) 108:147–57. 10.1016/j.jad.2007.10.01418067974
4. Borenstein AR, Copenhaver CI, Mortimer JA. Early-life risk factors for Alzheimer disease. Alzheimer Dis Assoc Disord. (2006) 20:63–72. 10.1097/01.wad.0000201854.62116.d716493239
5. Wynn JL, Levy O. Role of innate host defenses in susceptibility to early-onset neonatal sepsis. Clin Perinatol. (2010) 37:307–37. 10.1016/j.clp.2010.04.00120569810
6. Morton SU, Brodsky D. Fetal physiology and the transition to extrauterine life. Clin Perinatol. (2016) 43:395–407. 10.1016/j.clp.2016.04.00127524443
7. Wu L, Liu YJ. Development of dendritic-cell lineages. Immunity. (2007) 26:741–50. 10.1016/j.immuni.2007.06.00617582346
8. Langrish CL, Buddle JC, Thrasher AJ, Goldblatt D. Neonatal dendritic cells are intrinsically biased against Th-1 immune responses. Clin Exp Immunol. (2002) 128:118–23. 10.1046/j.1365-2249.2002.01817.x11982599
9. Willems F, Vollstedt S, Suter M. Phenotype and function of neonatal DC. Eur J Immunol. (2009) 39:26–35. 10.1002/eji.20083839119137537
10. Corinti S, Albanesi C, la Sala A, Pastore S, Girolomoni G. Regulatory activity of autocrine IL-10 on dendritic cell functions. J Immunol. (2001) 166:4312–8. 10.4049/jimmunol.166.7.431211254683
11. Hunt DWC, Huppertz HI, Jiang HJ, Petty RE. Studies of human cord blood dendritic cells: evidence for functional immaturity. Blood. (1994) 84:4333–43. 10.1182/blood.V84.12.4333.bloodjournal841243337994049
12. Papaioannou NE, Pasztoi M, Schraml BU. Understanding the functional properties of neonatal dendritic cells: a doorway to enhance vaccine effectiveness? Front immunol. (2019) 9:3123. 10.3389/fimmu.2018.0312330687326
13. De Wit D, Olislagers V, Goriely S, Vermeulen F, Wagner H, Goldman M, et al. Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood. (2004) 103:1030–2. 10.1182/blood-2003-04-121614504106
14. Zhang X, Zhivaki D, Lo-man R. Unique aspects of the perinatal. Nat Publ Gr. (2017) 17:495–507. 10.1038/nri.2017.5428627520
15. Nguyen M, Leuridan E, Zhang T, De Wit D, Willems F, van Damme P, et al. Acquisition of adult-like TLR4 and TLR9 responses during the first year of life. PLoS ONE. (2010) 5:e10407. 10.1371/journal.pone.001040720442853
16. Torok C, Lundahl J, Hed J, Lagercrantz H. Diversity in regulation of adhesion molecules (Mac-1 and L-selectin) in monocytes and neutrophils from neonates and adults. Arch Dis Child. (1993) 68:561–5. 10.1136/adc.68.5_Spec_No.5617686738
17. Yerkovich ST, Wikström ME, Suriyaarachchi D, Prescott SL, Upham JW, Holt PG. Postnatal development of monocyte cytokine responses to bacterial lipopolysaccharide. Pediatr Res. (2007) 62:547–52. 10.1203/PDR.0b013e318156810517805207
18. Li YP, Yu SL, Huang ZJ, Huang J, Pan J, Feng X, et al. An impaired inflammatory cytokine response to gram-negative LPS in human neonates is associated with the defective TLR-mediated signaling pathway. J Clin Immunol. (2015) 35:218–26. 10.1007/s10875-015-0128-625631527
19. Sharma AA, Jen R, Kan B, Sharma A, Marchant E, Tang A, et al. Impaired NLRP3 inflammasome activity during fetal development regulates IL-1β production in human monocytes. Eur J Immunol. (2015) 45:238–49. 10.1002/eji.20144470725311115
20. Leiber A, Graf B, Spring B, Rudner J, Köstlin N, Orlikowsky TW, et al. Neonatal monocytes express antiapoptotic pattern of Bcl-2 proteins and show diminished apoptosis upon infection with Escherichia coli. Pediatr Res. (2014) 76:142–9. 10.1038/pr.2014.7424850312
21. Winterberg T, Vieten G, Meier T, Yu Y, Busse M, Hennig C, et al. Distinct phenotypic features of neonatal murine macrophages. Eur J Immunol. (2015) 45:214–24. 10.1002/eji.20144446825329762
22. Angelone DF, Wessels MR, Coughlin M, Suter EE, Valentini P, Kalish LA, et al. Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-α production in vitro and in vivo. Pediatr Res. (2006) 60:205–9. 10.1203/01.pdr.0000228319.10481.ea16864705
23. Speer CP, Gahr M, Wieland M, Eber S. Phagocytosis-associated functions in neonatal monocyte-derived macrophages. Pediatr Res. (1988) 24:213–6. 10.1203/00006450-198808000-000152847109
24. Anderson DC, Abbassi O, Kishimoto TK, Koenig JM, McIntire L V, Smith CW. Diminished lectin-, epidermal growth factor-, complement binding domain-cell adhesion molecule-1 on neonatal neutrophils underlies their impaired CD18-independent adhesion to endothelial cells in vitro. J Immunol. (1991) 146:3372–9. 1709192
25. Nussbaum C, Gloning A, Pruenster M, Frommhold D, Bierschenk S, Genzel-Boroviczeny O, et al. Neutrophil and endothelial adhesive function during human fetal ontogeny. J Leukoc Biol. (2013) 93:175–84. 10.1189/jlb.091246823233729
26. Weinberger B, Laskin DL, Mariano TM, Sunil VR, DeCoste CJ, Heck DE, et al. Mechanisms underlying reduced responsiveness of neonatal neutrophils to distinct chemoattractants. J Leukoc Biol. (2001) 70:969–76. 10.1189/jlb.70.6.96911739560
27. Howard TH, Meyer WH. Chemotactic peptide modulation of actin assembly and locomotion in neutrophils. J Cell Biol. (1984) 98:1265−71. 10.1083/jcb.98.4.12656232281
28. Abughali N, Berger M, Tosi MF. Deficient total cell content of CR3 (CD11b) in neonatal neutrophils. Blood. (1994) 83:1086–92. 10.1182/blood.V83.4.1086.10867906565
29. Zhu J, Zhang H, Guo T, Li W, Li H, Zhu Y, et al. Quantitative proteomics reveals differential biological processes in healthy neonatal cord neutrophils and adult neutrophils. Proteomics. (2014) 14:1688–97. 10.1002/pmic.20140000924782442
30. Dhakal M, Miller MM, Zaghouani AA, Sherman MP, Zaghouani H. Neonatal basophils stifle the function of early-life dendritic cells to curtail Th1 immunity in newborn mice. J Immunol. (2015) 195:507–18. 10.4049/jimmunol.150002726034171
31. Guilmot A, Hermann E, Braud VM, Carlier Y, Truyens C. Natural killer cell responses to infections in early life. J Innate Immun. (2011) 3:280–8. 10.1159/00032393421411972
32. Le Garff-Tavernier M, Béziat V, Decocq J, Siguret V, Gandjbakhch F, Pautas E, et al. Human NK cells display major phenotypic and functional changes over the life span. Aging Cell. (2010) 9:527–35. 10.1111/j.1474-9726.2010.00584.x
33. Krampera M, Tavecchia L, Benedetti F, Nadali G, Pizzolo G. Intracellular cytokine profile of cord blood T-, and NK- cells and monocytes. Haematologica. (2000) 85:675–9. 10897117
34. Kohl S, Sigouroudinia M, Engleman EG. Adhesion defects of antibody-mediated target cell binding of neonatal natural killer cells. Pediatr Res. (1999) 46:755. 10.1203/00006450-199912000-0001810590035
35. Eberl G, Colonna M, Santo JP, McKenzie ANJ. Innate lymphoid cells: A new paradigm in immunology TL - 348. Innate lymphoid cells A new Paradig Immunol. (1970) 348:aaa6566.
36. Yu JC, Khodadadi H, Malik A, Davidson B, Yu JC. Innate Immunity of Neonates and Infants. Front Immunol. (2018) 9:1759. 10.3389/fimmu.2018.0175930105028
37. Bank U, Deiser K, Finke D, Hämmerling GJ, Arnold B, Schüler T. Cutting edge: innate lymphoid cells suppress homeostatic T cell expansion in neonatal mice. J Immunol. (2016) 196:3532–6. 10.4049/jimmunol.150164326983785
38. Baban B, Malik A, Bhatia J, Yu JC. Presence and profile of innate lymphoid cells in human breast milk. JAMA Pediatr. (2018) 172:594–6. 10.1001/jamapediatrics.2018.014829630693
39. Bermick JR, Lambrecht NJ, denDekker AD, Kunkel SL, Lukacs NW, Hogaboam CM, et al. Neonatal monocytes exhibit a unique histone modification landscape. Clin Epigenetics. (2016) 8:1–15. 10.1186/s13148-016-0265-727660665
40. de Jong E, Strunk T, Burgner D, Lavoie PM, Currie A. The phenotype and function of preterm infant monocytes: implications for susceptibility to infection. J Leukoc Biol. (2017) 102:645–56. 10.1189/jlb.4RU0317-111R28630102
41. Nash MJ, Frank DN, Friedman JE. Early microbes modify immune system development and metabolic homeostasis-the “Restaurant” hypothesis revisited. Front Endocrinol. (2017) 8:349. 10.3389/fendo.2017.0034929326657
42. White GP, Watt PM, Holt BJ, Holt PG. Differential patterns of methylation of the IFN-gamma promoter at CpG and Non-CpG Sites underlie differences in IFN-gamma Gene expression between human neonatal and adult CD45RO- T Cells. J Immunol. (2002) 168:2820–7. 10.4049/jimmunol.168.6.282011884451
43. Cuenca AG, Wynn JL, Moldawer LL, Levy O. Role of innate immunity in neonatal infection. Am J Perinatol. (2013) 30:105–12. 10.1055/s-0032-133341223297181
44. Dzidic M, Boix-Amorós A, Selma-Royo M, Mira A, Collado M. Gut microbiota and mucosal immunity in the neonate. Med Sci. (2018) 6:56. 10.3390/medsci603005630018263
45. Gensollen T, Blumberg RS. Correlation between early-life regulation of the immune system by microbiota and allergy development. J Allergy Clin Immunol. (2017) 139:1084–91. 10.1016/j.jaci.2017.02.01128390575
46. Gensollen T, Iyer SS, Kasper DL, Blumberg RS, Medical H. How colonization by microbiota in early life shapes the immune system. Science. (2016) 352:539–44. 10.1126/science.aad937827126036
47. Thaiss CA, Zmora N, Levy M, Elinav E. The microbiome and innate immunity. Nature. (2016) 535:65–74. 10.1038/nature1884727383981
48. Kollmann TR, Kampmann B, Mazmanian SK, Marchant A, Levy O. Protecting the newborn and young infant from infectious diseases: lessons from immune ontogeny. Immunity. (2017) 46:350–63. 10.1016/j.immuni.2017.03.00928329702
49. Noto A, Fanos V, Dessì A. Metabolomics in newborns. Adv Clin Chem. (2016) 74:35–61. 10.1016/bs.acc.2015.12.00627117660
50. Dessi A, Murgia A, Agostino R, Pattumelli MG, Schirru A, Scano P, et al. Exploring the role of different neonatal nutrition regimens during the first week of life by urinary GC-MS metabolomics. Int J Mol Sci. (2016) 17:265. 10.3390/ijms1702026526907266
51. Reinke SN, Walsh BH, Boylan GB, Sykes BD, Kenny LC, Murray DM, et al. 1H NMR derived metabolomic profile of neonatal asphyxia in umbilical cord serum: implications for hypoxic ischemic encephalopathy. J Proteome Res. (2013) 12:4230–9. 10.1021/pr400617m23931672
52. Deminice R, da Silva RP, Lamarre SG, Kelly KB, Jacobs RL, Brosnan ME, et al. Betaine supplementation prevents fatty liver induced by a high-fat diet: effects on one-carbon metabolism. Amino Acids. (2015) 47:839–46. 10.1007/s00726-014-1913-x25577261
53. Fanos V, Caboni P, Corsello G, Stronati M, Gazzolo D, Noto A, et al. Urinary (1)H-NMR and GC-MS metabolomics predicts early and late onset neonatal sepsis. Early Hum Dev. (2014) 90(Suppl. 1):S78–83. 10.1016/S0378-3782(14)70024-624709468
54. Andreas NJ, Hyde MJ, Gomez-Romero M, Lopez-Gonzalvez MA, Villasenor A, Wijeyesekera A, et al. Multiplatform characterization of dynamic changes in breast milk during lactation. Electrophoresis. (2015) 36:2269–85. 10.1002/elps.20150001125959062
55. Kraus WE, Muoio DM, Stevens R, Craig D, Bain JR, Grass E, et al. Metabolomic Quantitative Trait Loci (mQTL) mapping implicates the ubiquitin proteasome system in cardiovascular disease pathogenesis. PLoS Genet. (2015) 11:e1005553. 10.1371/journal.pgen.100555326540294
56. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly YM, et al. The microbial metabolites, short-chain fatty acids, regulate colonic treg cell homeostasis. Science. (2013) 341:569–73. 10.1126/science.124116523828891
57. Blanton LV, Charbonneau MR, Salih T, Barratt MJ, Venkatesh S, Ilkaveya O, et al. Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children. Science. (2016) 351:aad3311. 10.1126/science.aad331126912898
58. Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T, et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun. (2013) 4:1829. 10.1038/ncomms285223652017
59. Stewart CJ, Embleton ND, Marrs ECL, Smith DP, Nelson A, Abdulkadir B, et al. Temporal bacterial and metabolic development of the preterm gut reveals specific signatures in health and disease. Microbiome. (2016) 4:67. 10.1186/s40168-016-0216-828034304
60. Entner N, Doudoroff M. Glucose and gluconic acid oxidation of Pseudomonas saccharophila. J Biol Chem. (1952) 196:853–62. 12981024
61. Simonsen KA, Anderson-Berry AL, Delair SF, Dele Davies H. Early-onset neonatal sepsis. Clin Microbiol Rev. (2014) 27:21–47. 10.1128/CMR.00031-1324396135
62. Camacho-gonzalez A, Spearman PW, Diseases PI, Stoll BJ, Brumley GW, Drive U. Neonatal infections disease: evuluation of neonatal sepsis. Pediatr Clin North Am North Am. (2013) 60:367–89. 10.1016/j.pcl.2012.12.003
63. Bizzarro MJ, Raskind C, Baltimore RS, Gallagher PG. Seventy-five years of neonatal sepsis at Yale: 1928-2003. Pediatrics. (2005) 116:595–602. 10.1542/peds.2005-055216140698
64. Cancelier AC, Petronilho F, Reinke A, Constantino L, Machado R, Ritter C, et al. Inflammatory and oxidative parameters in cord blood as diagnostic of early-onset neonatal sepsis: a case-control study. Pediatr Crit Care Med. (2009) 10:467–71. 10.1097/PCC.0b013e318198b0e319307820
65. Melvan JN, Bagby GJ, Welsh DA, Nelson S, Zhang P. Neonatal sepsis and neutrophil insufficiencies. Int Rev Immunol. (2010) 29:315–48. 10.3109/0883018100379280320521927
66. Hogasen AK, Overlie I, Hansen TW, Abrahamsen TG, Finne PH, Hogasen K. The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency. J Perinat Med. (2000) 28:39–48. 10.1515/JPM.2000.00610765513
67. Aikio O, Vuopala K, Pokela ML, Hallman M. Diminished inducible nitric oxide synthase expression in fulminant early-onset neonatal pneumonia. Pediatrics. (2000) 105:1013–9. 10.1542/peds.105.5.101310790456
68. Yost CC, Cody MJ, Harris ES, Thornton NL, McInturff AM, Martinez ML, et al. Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates. Blood. (2009) 113:6419–27. 10.1182/blood-2008-07-17162919221037
69. Georgeson GD, Szony BJ, Streitman K, Kovács A, Kovács L, László A. Natural killer cell cytotoxicity is deficient in newborns with sepsis and recurrent infections. Eur J Pediatr. (2001) 160:478–82. 10.1007/s00431010077311548185
70. Robaina Castellanos GR, Riesgo Rodriguez S, de la C. Neonatal sepsis and neurodevelopment in very low birth weight infants in Matanzas, Cuba 2006-2010: a prospective cohort study. Medwave. (2016) 16:e6422. 10.5867/medwave.2016.02.642227097362
71. Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med. (2018) 6:223–30. 10.1016/S2213-2600(18)30063-829508706
72. Ng PC. Diagnostic markers of infection in neonates. Arch Dis Child Fetal Neonatal Ed. (2004) 89:F229-35. 10.1136/adc.2002.02383815102726
73. Wu YQ, Shen J, Zhou QL, Zhao HW, Liu LR, Liu X. Interleukin-6 and interleukin-8 in diagnosing neonatal septicemia. J Biol Regul Homeost Agents. (2016) 30:1107–13. 28078861
74. Ng PC, Lam HS. Biomarkers for late-onset neonatal sepsis: cytokines and beyond. Clin Perinatol. (2010) 37:599–610. 10.1016/j.clp.2010.05.00520813273
75. Meadow W, Rudinsky B. Inflammatory mediators and neonatal sepsis. rarely has so little been known by so many about so much. Clin Perinatol. (1995) 22:519–36. 10.1016/S0095-5108(18)30295-17671549
76. Gomez-Lopez N, Romero R, Maymon E, Kusanovic JP, Panaitescu B, Miller D, et al. Clinical chorioamnionitis at term IX: in vivo evidence of intra-amniotic inflammasome activation. J Perinat Med. (2019) 47:276–87. 10.1515/jpm-2018-027130412466
77. Kim CJ, Romero R, Chaemsaithong P, Chaiyasit N, Yoon BH, Kim YM. Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. Am J Obstet Gynecol. (2015) 213:S29–52. 10.1016/j.ajog.2015.08.04026428501
78. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol. (1998) 179:194–202. 10.1016/S0002-9378(98)70272-89704787
79. Boulanger LM. Immune proteins in brain development and synaptic plasticity. Neuron. (2009) 64:93–109. 10.1016/j.neuron.2009.09.00119840552
80. Carpentier PA, Palmer TD. Immune influence on adult neural stem cell regulation and function. Neuron. (2009) 64:79–92. 10.1016/j.neuron.2009.08.03819840551
81. Rainaldi MA, Perlman JM. Pathophysiology of Birth Asphyxia. Clin Perinatol. (2016) 43:409–22. 10.1016/j.clp.2016.04.00227524444
82. Hagberg H, Mallard C, Ferriero DM, Vannucci SJ, Levison SW, Vexler ZS, et al. The role of inflammation in perinatal brain injury. Nat Rev Neurol. (2015) 11:192–208. 10.1038/nrneurol.2015.1325686754
83. Aly H, Khashaba MT, El-Ayouty M, El-Sayed O, Hasanein BM. IL-1beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy. Brain Dev. (2006) 28:178–82. 10.1016/j.braindev.2005.06.00616181755
84. Chiesa C, Pellegrini G, Panero A, De Luca T, Assumma M, Signore F, et al. Umbilical cord interleukin-6 levels are elevated in term neonates with perinatal asphyxia. Eur J Clin Invest. (2003) 33:352–8. 10.1046/j.1365-2362.2003.01136.x12662167
85. Savman K, Blennow M, Gustafson K, Tarkowski E, Hagberg H. Cytokine response in cerebrospinal fluid after birth asphyxia. Pediatr Res. (1998) 43:746–51. 10.1203/00006450-199806000-000069621983
86. Okazaki K, Nishida A, Kato M, Kozawa K, Uga N, Kimura H. Elevation of cytokine concentrations in asphyxiated neonates. Biol Neonate. (2006) 89:183–9. 10.1159/00008918016244469
87. Morkos AA, Hopper AO, Deming DD, Yellon SM, Wycliffe N, Ashwal S, et al. Elevated total peripheral leukocyte count may identify risk for neurological disability in asphyxiated term neonates. J Perinatol. (2007) 27:365–70. 10.1038/sj.jp.721175017443199
88. Modgil S, Lahiri DK, Sharma VL, Anand A. Role of early life exposure and environment on neurodegeneration: implications on brain disorders. Transl Neurodegener. (2014) 3:9. 10.1186/2047-9158-3-924847438
89. Tremlett H, Bauer KC, Appel-Cresswell S, Finlay BB, Waubant E. The gut microbiome in human neurological disease: a review. Ann Neurol. (2017) 81:369–82. 10.1002/ana.2490128220542
90. Gilman SE, Cherkerzian S, Buka SL, Hahn J, Hornig M, Goldstein JM. Prenatal immune programming of the sex-dependent risk for major depression. Transl Psychiatry. (2016) 6:e822. 10.1038/tp.2016.9127244231
91. Vojdani A, Mumper E, Granpeesheh D, Mielke L, Traver D, Bock K, et al. Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15. J Neuroimmunol. (2008) 205:148–54. 10.1016/j.jneuroim.2008.09.00518929414
92. Ricci S, Businaro R, Ippoliti F, Lo Vasco VR, Massoni F, Onofri E, et al. Altered cytokine and BDNF levels in autism spectrum disorder. Neurotox Res. (2013) 24:491–501. 10.1007/s12640-013-9393-423604965
93. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water J. Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J Neuroimmunol. (2011) 232:196–9. 10.1016/j.jneuroim.2010.10.02521095018
94. Krakowiak P, Goines PE, Tancredi DJ, Ashwood P, Hansen RL, Hertz-Picciotto I, et al. Neonatal cytokine profiles associated with autism spectrum disorder. Biol Psychiatry. (2017) 81:442–51. 10.1016/j.biopsych.2015.08.00726392128
95. Saghazadeh A, Ataeinia B, Keynejad K, Abdolalizadeh A, Hirbod-Mobarakeh A, Rezaei N. Anti-inflammatory cytokines in autism spectrum disorders: a systematic review and meta-analysis. Cytokine. (2019) 123:154740. 10.1016/j.cyto.2019.15474031228728
96. Ohja K, Gozal E, Fahnestock M, Cai L, Cai J, Freedman JH, et al. Neuroimmunologic and neurotrophic interactions in autism spectrum disorders: relationship to neuroinflammation. Neuromolecular Med. (2018) 20:161–73. 10.1007/s12017-018-8488-829691724
97. Malik M, Sheikh AM, Wen G, Spivack W, Brown WT, Li X. Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects. Immunobiology. (2011) 216:80–5. 10.1016/j.imbio.2010.03.00120399529
98. Jenster M, Bonifacio SL, Ruel T, Rogers EE, Tam EW, Partridge JC, et al. Maternal or neonatal infection: association with neonatal encephalopathy outcomes. Pediatr Res. (2018) 83:747. 10.1038/pr.2017.246
99. Raymond SL, Stortz JA, Mira JC, Larson SD, Wynn JL, Moldawer LL. Immunological defects in neonatal sepsis and potential therapeutic approaches. Front Pediatr. (2017) 5:14. 10.3389/fped.2017.0001428224121
100. Harbeson D, Ben-Othman R, Amenyogbe N, Kollmann TR. Outgrowing the immaturity myth: the cost of defending from neonatal infectious disease. Front Immunol. (2018) 9:1077. 10.3389/fimmu.2018.0107729896192
101. Goodridge HS, Ahmed SS, Curtis N, Kollmann TR, Levy O, Netea MG, et al. Harnessing the beneficial heterologous effects of vaccination. Nat Rev Immunol. (2016) 16:392–400. 10.1038/nri.2016.4327157064
102. Mateen FJ, Shinohara RT, Sutter RW. Oral and inactivated poliovirus vaccines in the newborn: a review. Vaccine. (2013) 31:2517–24. 10.1016/j.vaccine.2012.06.02022728224
103. Traudt CM, McPherson RJ, Bauer LA, Richards TL, Burbacher TM, McAdams RM, et al. Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia. Dev Neurosci. (2013) 35:491–503. 10.1159/00035546024192275
104. Robertson NJ, Faulkner S, Fleiss B, Bainbridge A, Andorka C, Price D, et al. Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model. Brain. (2013) 136:90–105. 10.1093/brain/aws28523183236
105. Aden U, Favrais G, Plaisant F, Winerdal M, Felderhoff-Mueser U, Lampa J, et al. Systemic inflammation sensitizes the neonatal brain to excitotoxicity through a pro-/anti-inflammatory imbalance: key role of TNFalpha pathway and protection by etanercept. Brain Behav Immun. (2010) 24:747–58. 10.1016/j.bbi.2009.10.01019861157
106. Girard S, Sebire H, Brochu ME, Briota S, Sarret P, Sebire G. Postnatal administration of IL-1Ra exerts neuroprotective effects following perinatal inflammation and/or hypoxic-ischemic injuries. Brain Behav Immun. (2012) 26:1331–9. 10.1016/j.bbi.2012.09.001
107. Feng Y, Rhodes PG, Bhatt AJ. Dexamethasone pre-treatment protects brain against hypoxic-ischemic injury partially through up-regulation of vascular endothelial growth factor A in neonatal rats. Neuroscience. (2011) 179:223–32. 10.1016/j.neuroscience.2011.01.05021277350